Hospitals and Health Systems
PROVEN COUNSEL
Areas of Interest
innovation Centers
Navigate the many regulatory, legal and business requirements your revolutionary developments bring including:
- Intellectual Property
- Tax and Tax Exemption
- Data Privacy And Security
- Employee Benefits
- FDA
- Conflicts Of Interest and More
collaborative transformation
Unexpected partners are joining forces to innovate in bold and surprising ways, as they do, they face some of healthcare’s toughest challenges. We’re here to help with mergers, acquisitions, joint ventures and all other types of innovative collaborations.
- Regulatory Compliance
- Digital Health
- Intellectual Property
- Investment
- Tax
- Licensing
- Litigation
Consolidation and RestructurinG
Consolidating and restructuring hospital and health systems is a complex process that involves a range of critical planning and coordination steps to ensure the health, welfare and safety of hospital patients and mitigate legal, financial and other risks for the hospital and its officers and directors.
Digital healtH
At the forefront of the transforming Digital Health landscape McDermott works with hospitals and health systems to make sense of the changing digital landscape and implement strategies and tools that align with the most recent regulatory requirements.
- Telehealth/Telemedicine
- Health Information Technology
- Big Data and Data Strategies
- Data Privacy/Security HIPAA and State Laws
- Intellectual Property
340B LITIGATION TRACKER
McDermott+Consulting has launched a 340B Litigation Tracking Tool, a real-time resource following the 30+ state and federal 340B program legal challenges. No more searching online or sorting through your newsfeed for important case developments. This tracker, available 24/7 and regularly monitored by our team, delivers concise updates to help you make informed risk analyses on what’s next for your business in the evolving 340B landscape.
Corporate Governance
Healthcare corporations and their leadership face a host of legal and reputational challenges that must be addressed strategically and proactively. Our healthcare governance team, provides engaging, issue-based resources on the risk areas corporations face and how the general counsel’s office and the board can address them.
- Quality and Patient Safety
- Fiduciary Considerations
- Protocols and Structure
- Culture and Leadership for Radical Decision Making
general counsel’s corner
VALUE ADD OR VALIANT EFFORT: EXAMINING HOW TO USE THE VALUE-BASED SAFE HARBORS AND EXCEPTIONS FOR PHYSICIAN ARRANGEMENTS
It has been more than two years since the majority of the regulatory changes by the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) Office of Inspector General (OIG) comprising the Sprint to Coordinated Care (Sprint Rules) became effective, significantly updating the regulations for the Anti-Kickback Statute (AKS) and Physician Self-Referral Law (Stark Law). These regulatory updates have arguably been some of the most material and transformative changes to the Stark Law and AKS regulatory scheme in decades. As opposed to presenting new regulatory hurdles for stakeholders, the Sprint Rules are, for the most part, burden reducing, dulling some of the strict liability edges of the Stark Law, and widening the availability of AKS safe harbors to protect common, non-abusive arrangements. Indeed, the Sprint Rules were promulgated with the intention of providing the health care industry a “regulatory refresh” on the Stark Law and AKS, given these laws were promulgated decades ago and designed to govern fraud and abuse risks in a fee-for-service-centered payment world. As health care payment systems have marched (or meandered, depending on your vantage) toward a system that puts value at the forefront and shifts cost of care risk from payors to providers, the types of fraud and abuse risks presented by financial relationships governed by the Stark Law and AKS has also shifted. The Sprint Rules acknowledge this realignment, and, for arrangements that meet certain requirements, allow for compensation structures or the provision of remuneration to referral sources that may not have been possible prior to their finalization. However, these significant regulatory changes came at a time when the entire health care sector was responding to the COVID-19 pandemic. Thus, while many of the benefits of the Sprint Rules have been leveraged by stakeholders, utilization of those related to the Value-Based Exceptions and Safe Harbors (collectively, the Value-Based Rules) may be slower than would have otherwise been the case.
January 2023 | How to Avoid Deal Risks in Hospital Mergers and Acquisitions
December 2022 | Aligning Interests in Health Plan Joint Ventures
December 2022 | Healthcare Predictions for 2023: Hard Choices and Working Smarter
September 2022 | No Surprises Act Update: What You Need to Know about the August Final Rule
APRIL 2022 | HHS Announces Provider Relief Fund Late Reporting Pathway
APRIL 2022 | Two-Part Podcast Discussion: Priorities and Trends for the Compensation Committee
AUGUST 2021 | What CMS’ Split Billing Proposal Means for Health Providers
AUGUST 2021 | AI and Health Board Governance: Designing Your Governance Oversight Framework
AUGUST 2021 | OSHA Safety Requirements for Healthcare Employers to Watch
AUGUST 2021 | CMS Proposes Higher Penalties for Hospital Price Transparency Noncompliance
JULY 2021 | Mid-Year Check-in: 2021 Trends in Healthcare Antitrust Enforcement
Articles
October 30, 2023
October 6, 2023
September 13, 2023
September 8, 2023
NEW YORK PROPOSES REGULATIONS EXPANDING STATE’S ABILITY TO REGULATE PBMS
September 7, 2023
CMS ANNOUNCES NEW VOLUNTARY MULTI-PAYER PRIMARY CARE MODEL IN EIGHT STATES
August 28, 2023
Podcasts
DRIVING THE DEAL: HEALTHCARE ANTITRUST IN THE BIDEN ADMINISTRATION WITH ASHLEY FISHER
DRIVING THE DEAL: THE NO SURPRISES ACT WITH BRIAN STIMSON
Driving the Deal: Unwinding the Public Health Emergency with Brian Stimson
DRIVING THE DEAL: A LENDER’S PERSPECTIVE ON HEALTHCARE PE DEALS
DRIVING THE DEAL PODCAST: RESTRUCTURING AND BANKRUPTCY CONSIDERATIONS
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In
Dealmaking in the Sunlight: Navigating Public Hospital M&A
Collaboration Through Innovation Centers
FEATURED SERIES
This series covers a comprehensive exploration of hospital joint ventures, the innovative partnerships reshaping today’s healthcare landscape. This three-part series takes a deep dive into the contractual, regulatory and corporate governance issues parties must address for successful outcomes, including exploring the newest partnership shaking up healthcare—the payvider. Explore the recordings below and check back for their takeaways!
THE RISE OF THE PAYVIDER: JOINT VENTURES BETWEEN HEALTH SYSTEMS AND PAYORS
October 19, 2023
September 26, 2023
September 14, 2023
Videos
August 15, 2023
April 20, 2023
January 13, 2023
December 13, 2022
340B ESP AND HIPAA COMPLIANCE
December 6, 2022
November 1, 2022
Special Reports
EVENTS
HOSPITALS & HEALTH SYSTEMS SUMMIT 2023
LEARN MORE
HOSPITALS & HEALTH SYSTEMS INNOVATION SUMMIT 2022
2020 HOSPITAL & HEALTH SYSTEM INNOVATION SUMMIT
This summit will give C-suite executives, in-house counsel, investors and other healthcare leaders the insights they need to position their organizations to innovate, collaborate and grow even in the midst of disruption.
Hospitals & Health Systems Team Leads
Hospitals & Health Systems Team
Evelyn Atwater
Associate
Stacey Callaghan
Partner
Gary Davis
Partner
Partner
Dexter Golinghorst
Associate
Associate
Lisa Kaderabek
Counsel
Counsel
Partner
Associate
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Bernadette Broccolo
Counsel
James A. Cannatti III
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Associate
Partner
Partner
Emily Jane Cook
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner